RES Q1 2026 Earnings EPS Surprises to the Upside Amid Challenging Oilfield Environment BioXcel Therapeutics BTAI Q1 2026 Earnings EPS Misses Expectations as PreRevenue Biotech Focuses on Pipeline Progress UCB Q1 2026 Earnings EPS Slightly Below Estimates Shares Gain BJDX Q4 2023 Earnings Significant EPS Miss Despite Modest Stock Gain Upstream Bio UPB Q1 2026 Earnings NarrowerthanExpected Loss with No Revenue Yet RPT Q1 2026 Earnings Significant EPS Miss Stock Declines